Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?

J Nutr Health Aging. 2013 Jan;17(1):49-50. doi: 10.1007/s12603-013-0001-3.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Alzheimer Disease / immunology*
  • Alzheimer Disease / prevention & control*
  • Amyloid / drug effects
  • Amyloid / metabolism
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Disease Models, Animal
  • Humans
  • Immunization, Passive / methods*
  • Mice

Substances

  • Amyloid
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • gantenerumab
  • solanezumab
  • bapineuzumab
  • crenezumab